Field-Delivered Therapy Increases Treatment for Chlamydia and Gonorrhea

American Journal of Public Health

Volumn 93, Issue 6, 2003, Pages 882-884

  Steiner, Katherine C ^a,b   Davila, Veronica ^a   Kent, Charlotte K ^a   Chaw, Janice K ^a   Fischer, Lyn ^a   Klausner, Jeffrey D ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFIXIME; ANTIINFECTIVE AGENT;

CHLAMYDIASIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEASIBILITY STUDY; FOLLOW UP; GONORRHEA; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION RISK; PATIENT COMPLIANCE; REVIEW; SCREENING; UNITED STATES; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; DIRECTLY OBSERVED THERAPY; FEMALE; MALE; MASS SCREENING; PUBLIC HEALTH SERVICE; RISK FACTOR; STANDARD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHLAMYDIA INFECTIONS; CLINICAL PROTOCOLS; DIRECTLY OBSERVED THERAPY; FEMALE; GONORRHEA; HUMANS; MALE; MASS SCREENING; PUBLIC HEALTH ADMINISTRATION; RISK FACTORS; SAN FRANCISCO; UNITED STATES;

EID: 0037902899     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.93.6.882     Document Type: Review

References (6)

1. Sexually Transmitted Diseases Surveillance, 2001. Atlanta, Ga: Centers for Disease Control and Prevention; September 2002.
2. Cates W, Wasserheit JN. Genital chalmydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991;164:1771-1781.
3. Sweet RL. Pelvic Inflammatory disease: etiology, diagnosis, and treatment. Sex Transm Dis. 1981;8(suppl 4): 308-315.
4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3-17.
5. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS. 2002;13:91-101.
6. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis, consensus statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943-948.